Biological medicines have markedly changed prognoses for many conditions such as cancers, diabetes and autoimmune diseases.  

As biologics’ patents expire, biosimilars – highly similar versions of approved biologic brands – will be competitively marketed. This will lead to cost savings, increased access and treatment options, and improved patient outcomes.2

Read the HAH Bulletin to find out more.

Contributor
He Ako Hiringa
27 September 2021
4 minutes to Read + 15 minutes to Explore

Biological medicines are already used in Aotearoa New Zealand and with more being developed internationally, it’s important that you feel comfortable using them.

As an introduction, we’ve highlighted five key aspects of these medicines in an article and a series of short animated videos.

Contributor
He Ako Hiringa
11 August 2021